| Old Articles: <Older 37551-37560 Newer> |
|---|
 |
The Motley Fool
July 31, 2009
Matt Koppenheffer |
Wynn's Second Quarter: Cloudy, Chance of Sun Wynn Resorts' second-quarter results weren't pretty, but they were less nasty than expected.   |
The Motley Fool
July 30, 2009
Alyce Lomax |
A Lovelier Bare Escentuals? The mineral makeup company is less risky, but not risk-free. |
The Motley Fool
July 30, 2009
Robert Steyer |
Covance Advances Covance latest results produce more optimism than did some of its contract research peers. |
The Motley Fool
July 30, 2009
Rick Aristotle Munarriz |
Will Internet Radio Always Be Free? If it wants to charge for Web access, Sirius XM faces an uphill battle. |
The Motley Fool
July 30, 2009
John Rosevear |
The Emerging Trend That Starbucks Will Miss Or, how Starbucks just alienated a whole bunch of enthusiastic new customers. And why "gluten-free" is about to become big business |
The Motley Fool
July 30, 2009
Brian Orelli |
A Good Business Model for Bad Times Some businesses benefit when people are hurting. It's a beautiful time to be a pharmacy benefit manager, since that business model essentially results in them making more money when their customers save money. |
The Motley Fool
July 30, 2009
Toby Shute |
FMC Remains an Offshore Standout The subsea specialist is looking strong, despite the slowdown. |
The Motley Fool
July 30, 2009
Anders Bylund |
Buy Taiwan Semi and Sleep Like a Baby This tech stock acts like a small mutual fund -- with a hefty dividend. What's not to love? |
The Motley Fool
July 30, 2009
Chris Jones |
Coca-Cola Enterprises Fizzes Up But will the future fall flat for the soft-drink bottler? |
The Motley Fool
July 30, 2009
Brian Orelli |
A Little Help From the Enemy Unfortunately, it won't last. AstraZeneca went over a small patent cliff, but its competitors were nice enough to throw it some climbing gear. |
| <Older 37551-37560 Newer> Return to current articles. |
